![](https://investorshub.advfn.com/uicon/64308.png?cb=1526891968)
Friday, June 01, 2007 10:52:14 AM
Friday June 1, 8:00 am ET
--Hires Industry Veteran as Executive Vice President of Instrumentation--
MIAMI, June 1 /PRNewswire-FirstCall/ -- eXegenics, Inc., (OTC Bulletin Board: EXEG - News), doing business as Opko Health, today announced that it has entered into an agreement to acquire Ophthalmic Technologies, Inc. (OTI), a private Canadian company providing innovative patient imaging systems to eye care professionals worldwide. Additionally, Opko announced it has hired Steven Verdooner as Executive Vice President of Instrumentation, a newly created position.
"It is fitting that among our first actions as Opko Health is the acquisition of a respected ocular diagnostics firm and the hiring of an experienced senior manager from the diagnostics industry," said Dr. Philip Frost, Chairman and CEO of Opko Health. "There is the potential for powerful synergies between our therapeutics pipeline and the diagnostic systems and devices used by eye care professionals, and we believe OTI will be a good strategic foundation for that business. We are delighted that Steve Verdooner is joining Opko and believe his extensive experience in ophthalmic diagnostic instrumentation will be very valuable as we build our presence in this sector."
Toronto-based OTI provides technologically advanced, easy-to-use diagnostic and imaging equipment to the ophthalmology community. It markets a full line of advanced ophthalmic ultrasound and imaging products used by eye care professionals for both routine and specialized care. The company's SLO/OCT system is a breakthrough product offering unique advantages over current technology and providing a flexible platform that can process a wide variety of diagnostic tests. OTI has offices in Canada, the U.S. and the U.K. and a growing distributor network that currently covers more than 40 countries.
Rishard Weitz, President and CEO of OTI said, "As a team that has successfully commercialized innovative ophthalmic diagnostic imaging technologies, we are pleased to join forces with Opko, where we see the combination of strategic vision and successful companies with advanced technologies having the potential to create a new leader in the growing ophthalmology field."
According to the terms of the agreement with OTI, Opko has purchased one- third of the outstanding common shares of the company and has received an exclusive option to purchase the remaining shares over a period of approximately six months. Further details of the agreement are included in the company's 8-K filing with the Securities and Exchange Commission.
Steven Verdooner joins Opko from Ophthalmic Imaging Systems (OIS), a market leader in the field of ophthalmic digital imaging and informatics. Mr. Verdooner co-founded OIS in 1984 and played a major role in its growth and market success, including the development and marketing of revolutionary new ophthalmic imaging systems. In his more than 20 years at OIS, Mr. Verdooner had responsibility for a wide variety of functional areas, serving as Executive Vice President, President, Chief Executive Officer and Chairman. He received a B.S. degree from the University of California, Davis.
Source: eXegenics, Inc.
Recent OPK News
- OPKO Health to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/31/2024 02:48:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:29:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:07:44 PM
- OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 09:02:37 PM
- AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • GlobeNewswire Inc. • 03/05/2024 01:52:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 09:05:23 PM
- NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st • PR Newswire (US) • 02/28/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:54 PM
- OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/16/2024 09:53:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:07:24 PM
- NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China • PR Newswire (US) • 02/05/2024 01:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 08:30:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:56:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:09:07 PM
- OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes • GlobeNewswire Inc. • 01/09/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:10:34 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM